ArticlePharmaceutics2022

Imatinib Optimized Therapy Improves Major Molecular Response Rates in Patients with Chronic Myeloid Leukemia.

Hyacinthe Johnson-Ansah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.